Tag: HanchorBio Inc
HanchorBio Announces First Patient Dosed in the Phase 1 Multi-Regional Clinical...
HanchorBio Inc., a global clinical-stage biotechnology company focusing on the discovery and development of innovative immuno-biomedicines to treat a wide variety of...
HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies
HanchorBio Inc., a global clinical-stage biotechnology company focusing on the discovery and development of innovative immuno-biomedicines, and Shanghai Henlius Biotech, Inc., a...
HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial...
HanchorBio Received IND Approval of HCB101 Multi-Regional Clinical Trial By Taiwan FDA
HanchorBio Inc., a global clinical-stage biotechnology company...
HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of...
HanchorBio Received IND Clearance of HCB101 Multi-regional Clinical Trial By US FDA
HanchorBio Inc., a global clinical-stage biotechnology company...
